As of Mar 27
| +0.013 / +1.33%|
The 2 analysts offering 12-month price forecasts for StemCells Inc have a median target of 3.63, with a high estimate of 5.00 and a low estimate of 2.25. The median estimate represents a +266.90% increase from the last price of 0.99.
The current consensus among 2 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.